Rubicon Research Ltd approves Q2 FY27 results, with consolidated revenue of ₹576.38 crore and net profit of ₹90.43 crore
- Revenue rose 39.9% year on year and 7.9% sequentially; net profit increased 67.9% year on year and 6.7% sequentially.
- Calculated EBITDA operating margin was 25.0%.
- Deloitte’s limited-review conclusion was unmodified; results for nine subsidiaries were management-certified, and the proposed Kia Health Tech amalgamation had not become effective.
